{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:44:16Z","timestamp":1769478256946,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis B virus (HBV) remains a major health concern particularly in regions with intermediate-to-high endemicity such as Vietnam. Occult hepatitis B infection (OBI) defined as the presence of replication-competent HBV DNA in the absence of detectable hepatitis B surface antigen (HBsAg) poses challenges for diagnosis and blood safety. However, data on OBI among Vietnam\u2019s ethnic minority populations are scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among 267 HBsAg-negative ethnic minority students at Thai Nguyen University of Medicine and Pharmacy in 2024. Serum samples were screened for HBV serological markers (anti-HBs, anti-HBc) using commercial ELISAs. HBV DNA was extracted, amplified by nested PCR targeting a conserved S\/P region, and sequenced for genotyping and mutational analysis. Quantitative real-time PCR (qPCR) was used to assess viral loads.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among participants, 57% were susceptible (anti-HBs\u2013\/anti-HBc\u2013), 27% exhibited vaccine-induced immunity, 12% had resolved infections, and 4% showed isolated anti-HBc positivity. Overall, 16% were anti-HBc positive, indicating prior exposure. HBV DNA was detected in two samples (0.7%), both with undetectable viral loads by qPCR. One case represented seronegative OBI and the other seropositive OBI. Phylogenetic analysis classified both isolates as genotype B. Mutational analysis identified substitutions K122R, F200Y, Y206C, and I187V, with S117N uniquely present in one isolate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides the first evidence of OBI among ethnic minority students in northern Vietnam. Although prevalence was low, the high proportion of HBV-susceptible individuals highlights ongoing vulnerability and underscores the need for strengthened immunization, awareness, and surveillance programs in underserved communities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12347-7","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:55:35Z","timestamp":1766458535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["First identification of occult hepatitis B infection among ethnic minority students in Thai Nguyen, Vietnam"],"prefix":"10.1186","volume":"26","author":[{"given":"Vu Nhi","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Chi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Hai","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong Thi Phuong","family":"Thao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao Thi","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Thi Thu","family":"Hien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Thi Thanh","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Xuan","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Tien","family":"Dung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong Van","family":"Cuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Huu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Linh","family":"Toan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Truong Nhat","family":"My","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"12347_CR1","unstructured":"WHO. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva. Licence: CC BY-NC-SA 3.0 IGO.; 2024."},{"key":"12347_CR2","first-page":"100468","volume":"24","author":"B Flower","year":"2022","unstructured":"Flower B, Du Hong D, Vu Thi Kim H, Pham Minh K, Geskus RB, Day J, et al. Seroprevalence of hepatitis B, C and D in vietnam: A systematic review and meta-analysis. Lancet Reg Health West Pac. 2022;24:100468.","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"12347_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397\u2013408.","journal-title":"J Hepatol"},{"key":"12347_CR4","doi-asserted-by":"crossref","unstructured":"Tung TT, Schmid J, Nghia VX, Cao LC, Linh LTK, Rungsung I, et al. Low risk of occult hepatitis B infection among Vietnamese blood donors. Pathogens. 2022;11(12).","DOI":"10.3390\/pathogens11121524"},{"issue":"12","key":"12347_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/23744235.2022.2115126","volume":"54","author":"WY Xie","year":"2022","unstructured":"Xie WY, Sun C, He H, Deng C, Sheng Y. Estimates of the prevalence of occult HBV infection in asia: a systematic review and meta-analysis. Infect Dis (Lond). 2022;54(12):881\u201396.","journal-title":"Infect Dis (Lond)"},{"issue":"10","key":"12347_CR6","doi-asserted-by":"publisher","first-page":"e0312126","DOI":"10.1371\/journal.pone.0312126","volume":"19","author":"MN Mbencho","year":"2024","unstructured":"Mbencho MN, Hafza N, Cao LC, Mingo VN, Achidi EA, Ghogomu SM, et al. Incidence of occult hepatitis B infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon. PLoS ONE. 2024;19(10):e0312126.","journal-title":"PLoS ONE"},{"issue":"15","key":"12347_CR7","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3748\/wjg.v17.i15.1927","volume":"17","author":"ZN Said","year":"2011","unstructured":"Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17(15):1927\u201338.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"12347_CR8","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1128\/JCM.00145-11","volume":"49","author":"X Zheng","year":"2011","unstructured":"Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol. 2011;49(5):1730\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"12347_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/vox.12073","volume":"106","author":"P Jutavijittum","year":"2014","unstructured":"Jutavijittum P, Andernach IE, Yousukh A, Samountry B, Samountry K, Thammavong T, et al. Occult hepatitis B infections among blood donors in Lao PDR. Vox Sang. 2014;106(1):31\u20137.","journal-title":"Vox Sang"},{"issue":"1","key":"12347_CR10","doi-asserted-by":"publisher","first-page":"21589","DOI":"10.1038\/s41598-025-05409-y","volume":"15","author":"OV Kalinina","year":"2025","unstructured":"Kalinina OV, Lichnaia EV, Bui NTT, Starkova DA, Petrova OA, Tran NT, et al. Parenteral viral hepatitis among students in Da Nang, Vietnam, and insights into new hepatitis B virus genotype B classification. Sci Rep. 2025;15(1):21589.","journal-title":"Sci Rep"},{"issue":"10003","key":"12347_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355.","journal-title":"Lancet"},{"key":"12347_CR12","doi-asserted-by":"crossref","unstructured":"Hoan NX, Hoechel M, Tomazatos A, Anh CX, Pallerla SR, Linh LTK, et al. Predominance of HBV genotype B and HDV genotype 1 in Vietnamese patients with chronic hepatitis. Viruses. 2021;13(2).","DOI":"10.3390\/v13020346"},{"key":"12347_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-380888-2.00002-9","volume":"108","author":"JH Kao","year":"2010","unstructured":"Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010;108:21\u201372.","journal-title":"Adv Cancer Res"},{"issue":"3","key":"12347_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jinf.2014.10.015","volume":"70","author":"C Mirabelli","year":"2015","unstructured":"Mirabelli C, Surdo M, Van Hemert F, Lian Z, Salpini R, Cento V, et al. Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. J Infect. 2015;70(3):288\u201398.","journal-title":"J Infect"},{"issue":"1","key":"12347_CR15","doi-asserted-by":"publisher","first-page":"ofy356","DOI":"10.1093\/ofid\/ofy356","volume":"6","author":"MR Ciardi","year":"2019","unstructured":"Ciardi MR, Iannetta M, Zingaropoli MA, Salpini R, Aragri M, Annecca R, et al. Reactivation of hepatitis B virus with Immune-Escape mutations after Ocrelizumab treatment for multiple sclerosis. Open Forum Infect Dis. 2019;6(1):ofy356.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"12347_CR16","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1128\/JVI.06353-11","volume":"86","author":"C Wu","year":"2012","unstructured":"Wu C, Deng W, Deng L, Cao L, Qin B, Li S, et al. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol. 2012;86(8):4658\u201369.","journal-title":"J Virol"},{"issue":"Pt 11","key":"12347_CR17","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1099\/vir.0.066886-0","volume":"95","author":"J Fan","year":"2014","unstructured":"Fan J, Wang Y, Xiong H, Guo X, Cheng YC. Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility. J Gen Virol. 2014;95(Pt 11):2523\u201330.","journal-title":"J Gen Virol"},{"issue":"1","key":"12347_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2478\/jtim-2023-0010","volume":"11","author":"HJ Fu","year":"2023","unstructured":"Fu HJ, Zhou M, Huang ZH, Chen YX, Wu XX. Severe acute hepatitis of unknown origin in children: clinical issues of concern. J Transl Int Med. 2023;11(1):19\u201323.","journal-title":"J Transl Int Med"},{"issue":"4","key":"12347_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2478\/jtim-2024-0015","volume":"12","author":"J Wu","year":"2024","unstructured":"Wu J, Wang H, Xiang Z, Jiang C, Xu Y, Zhai G, et al. Role of viral hepatitis in pregnancy and its triggering mechanism. J Transl Int Med. 2024;12(4):344\u201354.","journal-title":"J Transl Int Med"},{"issue":"1","key":"12347_CR20","first-page":"1","volume":"1","author":"Z Shi","year":"2012","unstructured":"Shi Z, Li X, Yang Y, Ma L, Schreiber A. Obstetrical management of fulminant viral hepatitis in late pregnancy. Reproductive Syst Sex Disorders. 2012;1(1):1\u20135.","journal-title":"Reproductive Syst Sex Disorders"},{"issue":"11","key":"12347_CR21","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1002\/hep4.2064","volume":"6","author":"O Alshuwaykh","year":"2022","unstructured":"Alshuwaykh O, Daugherty T, Cheung A, Goel A, Dhanasekaran R, Ghaziani TT, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatol Commun. 2022;6(11):3052\u201361.","journal-title":"Hepatol Commun"},{"issue":"6","key":"12347_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.cgh.2024.01.045","volume":"22","author":"MH Lee","year":"2024","unstructured":"Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, et al. Chronic viral hepatitis B and C outweigh MASLD in the associated risk of cirrhosis and HCC. Clin Gastroenterol Hepatol. 2024;22(6):1275\u201385. e2.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:20:49Z","timestamp":1769440849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12347"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12347-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Institutional Review Board of Thai Nguyen University of Medicine and Pharmacy, Vietnam, (Approval No. 257\/\u0110HYD-H\u0110\u0110\u0110). All participants provided written informed consent prior to enrollment. Study procedures adhered to the principles of the Declaration of Helsinki and local ethical regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}